Zebra Medical Vision Wins UK Government Funding for AI-Based Osteoporotic Fracture Prevention Model


Zebra Medical Vision Wins UK Government Funding for AI-Based Osteoporotic Fracture Prevention Model

SHEFAYIM, Israel – (COMMERCIAL THREAD) – Zebra medical vision, the deep learning medical imaging analysis company, is one of the organizations selected to receive funding, which was ad on June 16, 2021. The AI ​​Prize makes available £ 140million over four years to accelerate the testing and evaluation of artificial intelligence technologies that meet the goals set out in the NHS Long Term Plan.

The award aims to increase the impact of AI-based technologies to help solve clinical and operational challenges in the NHS and healthcare settings. It will accelerate the most promising technologies throughout the regulatory process by creating an evidence base to demonstrate the effectiveness and safety of AI-based technologies in health and social services.

With this award, Zebra Medical Vision will be able to clinically validate the value of AI in population-level opportunistic screening for NHS patients, while further expanding the preventive care pathway to identify those at risk. risk of osteoporosis, positioning the technology for the NHS – wide-scale adoption. Together with respected partners, the Royal Osteoporosis Society and the Universities of Oxford and Cambridge, the award will facilitate a multi-center, multi-year study at five different NHS sites, demonstrating how the AI-activated spinal fracture pathway will work in reality to impact patient outcomes.

“This grant is another important step in our journey towards a fully comprehensive and scalable AI solution for areas of population health. This prestigious grant joins our R&D collaboration with NHS Greater Glasgow & Clyde to co-develop AI-based osteoporosis prevention services, ”said Zohar Elhanani, CEO of Zebra Medical Vision. “We are honored to have been chosen by the NHS time and time again and we are grateful for the opportunity to demonstrate our breakthrough technology in the areas of spinal fractures for the benefit of the general population. ”

The AI ​​Award is one of the programs that make up the NHS AI Lab, directed by NHSX and delivered in partnership with the Collaborative accelerated access (AAC) and National Institute for Health Research (NIHR).

Dan Bamford, Deputy Director AI Award, Accelerated Access Collaborative, said:
“We look forward to working with them as they further develop and test their technology, so that more patients can benefit from this cutting-edge artificial intelligence.”

Dr Indra Joshi, Director of AI, NHSX, said:
“With this latest round of AI award winners, we now have incredible expertise in a wide range of clinical and operational areas. With this award, Zebra Medical Vision will be at the forefront of applying artificial intelligence in new ways to transform health and care. ‘

About Zebra Medical Vision

Zebra Medical Vision’s AI solutions enable healthcare systems to identify patients at risk for chronic disease, enabling them to fill treatment gaps and initiate preventive care.

Analyzing millions of clinical images in real time, the AI-based solution detects various medical indications and immediately alerts the health actors concerned, triggering new care paths. Zebra Medical Vision’s solutions integrate with existing radiology workflows, including cardiology, bone health, and the world’s first multimodal triage for mammograms, CT scans and X-rays.

Website: https://www.zebra-med.com/

About the NHSX
The NHSX is a joint unit of teams from the Department of Health and Welfare and NHS England and Improvement, which advances the digital transformation of health and social services. www.nhsx.nhs.uk

The Accelerated Access Collaborative (AAC) is a unique partnership between patient groups, government agencies, industry and NHS bodies, who work together to streamline the adoption of new innovations in healthcare. www.england.nhs.uk/aac

The National Institute of Health and Research (NIHR) provides the people, facilities, and technology that enable research to thrive. www.nihr.ac.uk

View the source version on businesswire.com: https://www.businesswire.com/news/home/20210617005456/en/

Previous Hidden black scientists have proven polio vaccine to work
Next Braxia Scientific receives Government of Canada funding to complete first-of-its-kind clinical trial of ketamine for bipolar depression

No Comment

Leave a reply

Your email address will not be published.